America’s Next AI Accelerator Constraint: Heat, Power and the End of ‘Just Add GPUs’ (UF HWCE)
UF researchers have developed a hybrid photonic–electronic neural network that performs feature extraction using light, marking a breakthrough designed to overcome the energy and speed limits of traditional AI computing.
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (Globe Newswire)
UF startup Axogen, Inc., announced that the U.S. Food and Drug Administration has approved the Biologics License Application for AVANCE® (acellular nerve allograft-arwx).
New Moby Dick-Like Termite Species Discovered (UF/IFAS)
An international research team led by UF entomologist Rudolf Scheffrahn discovered a new South American termite species, Cryptotermes mobydicki, named for its whale-like elongated head and hidden mandibles.
Tech Tuesday: University of Florida Research Lab Develops Polymers From Corn (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate spotlights Dr. Gregory Hudalla’s research on a sweet-corn-derived polymer that could transform how medications are stabilized and stored.
Common Water Pill May Help HIV Medicines Work Faster and Reduce Inflammation, Early Study Suggests (UF Scripps)
UF researchers have found that spironolactone, an FDA-approved medication commonly prescribed for heart and blood pressure conditions, may be a useful add-on to standard HIV treatment.
Researchers Find Vital Clue in the Progression of Type 1 Diabetes (UF Health)
UF researchers have added an important piece to the puzzle in understanding the progression of type 1 diabetes.
Tech Tuesday: UF Researchers Develop AI Models To Optimize Biofuel Production (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate features a graduate student from the Sustainable Process Design Laboratory at the University of Florida.
UF Scientists Using Gatorade Royalties To Support Groundbreaking Research (The Gainesville Sun)
Celebrating 60 years of Gatorade, UF researchers highlight how the iconic sports drink, born from Dr. Robert Cade’s 1965 discoveries, continues to fuel groundbreaking research across the university.
Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia (Globe Newswire)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced that it received Rare Pediatric Disease designation from the U.S. Food and Drug Administration (FDA) for SGT-212, the Company’s investigational gene therapy for Friedreich’s ataxia (FA).
As Holiday Shopping Season Nears, UF Experts Warn Retail Theft Is Growing More Sophisticated (UF News)
UF Innovate | Accelerate client Loss Prevention Research Council and its affiliated UF researchers offer evidence-based insights as retailers report rising crime and growing safety concerns.